| Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker CE Redon, AJ Nakamura, OA Martin, PR Parekh, US Weyemi, ... Aging (Albany NY) 3 (2), 168, 2011 | 220 | 2011 |
| γ-H2AX and other histone post-translational modifications in the clinic CE Redon, U Weyemi, PR Parekh, D Huang, AS Burrell, WM Bonner Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1819 (7), 743-756, 2012 | 137 | 2012 |
| Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells P Parekh, L Motiwale, N Naik, KVK Rao Experimental and Toxicologic Pathology 63 (1-2), 167-173, 2011 | 119 | 2011 |
| NADPH oxidases NOXs and DUOXs as putative targets for cancer therapy U Weyemi, C E Redon, P R Parekh, C Dupuy, W M Bonner Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 97 | 2013 |
| The histone variant H2A. X is a regulator of the epithelial–mesenchymal transition U Weyemi, CE Redon, R Choudhuri, T Aziz, D Maeda, M Boufraqech, ... Nature communications 7 (1), 10711, 2016 | 80 | 2016 |
| Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model JS Dickey, Y Gonzalez, B Aryal, S Mog, AJ Nakamura, CE Redon, U Baxa, ... PloS one 8 (8), e70575, 2013 | 76 | 2013 |
| Inactivation of NADPH Oxidases NOX4 and NOX5 Protects Human Primary Fibroblasts from Ionizing Radiation-Induced DNA Damage U Weyemi, CE Redon, T Aziz, R Choudhuri, D Maeda, PR Parekh, ... Radiation research 183 (3), 262-270, 2015 | 67 | 2015 |
| Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis P Parekh, KVK Rao Cell biology international 31 (1), 35-43, 2007 | 57 | 2007 |
| NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease U Weyemi, CE Redon, T Aziz, R Choudhuri, D Maeda, PR Parekh, ... Proceedings of the National Academy of Sciences 112 (7), 2121-2126, 2015 | 46 | 2015 |
| Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells ET Chang, PR Parekh, Q Yang, DM Nguyen, F Carrier Oncotarget 7 (9), 10578, 2016 | 39 | 2016 |
| Hypothermia postpones DNA damage repair in irradiated cells and protects against cell killing BJ Baird, JS Dickey, AJ Nakamura, CE Redon, P Parekh, YV Griko, K Aziz, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 711 (1 …, 2011 | 36 | 2011 |
| SOD2 deficiency promotes aging phenotypes in mouse skin U Weyemi, PR Parekh, CE Redon, WM Bonner Aging (Albany NY) 4 (2), 116, 2012 | 31 | 2012 |
| Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol AG Georgakilas, CE Redon, NF Ferguson, TB Kryston, P Parekh, ... Cancer letters 353 (2), 248-257, 2014 | 26 | 2014 |
| Contribution of Dual Oxidase 2 (DUOX2) to Hyper-Radiosensitivity in Human Gastric Cancer Cells DM Nguyen, PR Parekh, ET Chang, NK Sharma, F Carrier Radiation research 184 (2), 151-160, 2015 | 14 | 2015 |
| In vivo expression of MHC class I genes depends on the presence of a downstream barrier element H Cohen, P Parekh, Z Sercan, A Kotekar, JD Weissman, DS Singer PloS one 4 (8), e6748, 2009 | 9 | 2009 |
| Predictive biomarkers for response to Trametinib in non-small cell lung cancer BGP Parekh PR, Botting GM, Thurber DB, Boruszczak M, Murphy W Tumour Biol. doi: 10.3233/TUB-220009. PMID: 36502357 44 (1), 249-267, 2022 | 5* | 2022 |
| DUOX2, a New Biomarker for Disseminated Gastric Cancer’s Response to Low Dose Radiation in Mice PR Parekh, E Solano-Gonzalez, MB Martins, X Ma, K Tighe, A Casildo, ... Cancers 13 (16), 4186, 2021 | 1 | 2021 |
| Evaluation of surrogate tissues as indicators of drug activity in a melanoma skin model PR Parekh, R Choudhuri, U Weyemi, OA Martin, WM Bonner, CE Redon Cancer Medicine 5 (8), 1731-1741, 2016 | 1 | 2016 |
| HDAC9 and 11 contribute to UV resistance in melanoma cells ET Chang, PR Parekh, Q Yang, F Carrier Cancer Research 75 (15_Supplement), 2116-2116, 2015 | 1 | 2015 |
| Investigating chemopotentiation by low-dose fractionated radiation therapy for disseminated intra-abdominal gastric cancer. F Carrier, P Parekh, E Solano-Gonzalez, X Ma, K Tighe, A Casildo, ... Journal of Clinical Oncology 39 (3_suppl), 242-242, 2021 | | 2021 |
